Influence of Rimantadine, Ribavirine and Triazavirine on Influenza A Virus Replication in Human Monolayer and Lymphoblastoid Cell Lines

QR Code

Influence of Rimantadine, Ribavirine and Triazavirine on Influenza A Virus Replication in Human Monolayer and Lymphoblastoid Cell Lines

The influence of antivirals, such as rimantadine, ribavirine and triazavirine on influenza virus replication in human cell cultures was evaluated. All the antivirals inhibited viral nucleoprotein NP synthesis. The strongest effect was shown for ribavirine in lung carcinoma A-549 cells and endothelia...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. D. Smirnova, D. M. Danilenko, M. YU. Eropkin, E. G. Deeva, O. I. Kiselev
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	influenza virus cell cultures apoptosis proliferation stimulation antivirals
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/407
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1)
by: S. A. Loginova, et al.
Published: (2020-05-01)

New Betulin Derivatives in Combination with Rimantadine for Inhibition of Influenza Virus Reproduction
by: O. V. Savinova, et al.
Published: (2020-05-01)

Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

nucleoside analogues for the treatment of influenza: history and experience
by: K. V. Kasianenko, et al.
Published: (2019-10-01)

Inhibition of Tick-Borne Encephalitis Virus Replication with Eprosartan and Ribavirin In Vitro and In Vivo
by: G. N. Leonova, et al.
Published: (2020-12-01)

Therapeutic Use of <i>Parerythrobacter</i> sp. M20A3S10, a Marine Bacterium, Targeting Influenza Viruses and Flaviviruses
by: Kyeong-Seo Moon, et al.
Published: (2025-07-01)

Molecular Genetic Mechanisms of Influenza A Virus Replication and Mechanisms of Action of Etiotropic Medications
by: M. N. Dunaeva
Published: (2024-06-01)

Bat Influenza M2 Shows Functions Similar to Those of Classical Influenza A Viruses
by: Wenyu Yang, et al.
Published: (2025-06-01)

The Possibilities of Etiotropic Therapy for Influenza and ARVI with Taking into Account the Period of Hospitalization and the Risk of Developing Secondary Complications
by: V. K. Verevshchikov, et al.
Published: (2020-05-01)

Antiviral Activity of Kagocel® on the Model of Experimental Lethal Influenza Infection
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Study of the Antiviral Activity of Drugs and Their Combination Against the Influenza A Virus
by: E. N. Vetrova, et al.
Published: (2025-02-01)

Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1)
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

In vitro Investigation of Ingavirin® Efficacy Against Influenza B Virus
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
by: A. V. Averyanov, et al.
Published: (2020-05-01)

Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis
by: A. I. Gubenko, et al.
Published: (2024-04-01)

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs
by: E. A. Prokopyeva, et al.
Published: (2019-12-01)

Assessing the fitness of distinct clades of influenza A (H9N2) viruses
by: S. Schultz-Cherry, et al.
Published: (2013-01-01)

Investigation of in vitro Activity of Ingavirin® Against Influenza Virus A (H3N2)
by: S. YA. Loginova, et al.
Published: (2020-05-01)

BASIC SURFACE MARKERS OF FUNCTIONAL ACTIVITY T-LYMPHOCYTES
by: L. S. Litvinova, et al.
Published: (2014-07-01)

Specific Influenza Therapy: Current State and Prospects (Review)
by: A. I. Odnovorov, et al.
Published: (2020-02-01)

Ribavirin Prophylaxis and Therapy of Experimental West Nile Fever
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Seaweed-Derived Sulfated Polysaccharides as Potential Agents for Prevention and Treatment of Inﬂuenza and COVID-19
by: N. N. Besednova, et al.
Published: (2021-10-01)

Study of the Protective Activity of Thymogen® Dosed Nasal Spray on a Model of Experimental Influenza Pneumonia in Laboratory Animals
by: V. V. Zarubaev, et al.
Published: (2024-01-01)

Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice
by: S. Ya. Loginova, et al.
Published: (2020-05-01)

Investigation of Prophylactic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice
by: S. Ya. Loginova, et al.
Published: (2020-05-01)

The role of lysosomal cysteine proteases in tumor progression
by: M. S. Korovin, et al.
Published: (2009-04-01)

Evaluation of the Molecular Effects of the Anticancer Adjuvant Valproic Acid on HEK293T Cells
by: Feyza Nur Tuncer, et al.
Published: (2024-12-01)

Investigation of Triazavirin Antiviral Activity Against Tick-Borne Encephalitis Pathogen in Cell Culture
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Comparative clinical and economic evaluation of two alternative antiviral therapy regimens for influenza patients
by: I. I. Tokin, et al.
Published: (2018-07-01)

The efficiency and safety of enisamium iodide and umifenoviri in ARVI treatment in real clinical practice
by: V. V. Gordienko, et al.
Published: (2024-01-01)

Etiologic Characteristics of Influenza Epidemics on the Territory of Russia in the Period of Pandemic COVID-19 in 2020–2023
by: P. A. Petrova, et al.
Published: (2024-07-01)

The Epidemiological Situation of Influenza in the World and Russia in the Season 2014 – 2015
by: L. S. Karpova, et al.
Published: (2015-08-01)

Experimental Medications Made with <i>Сetraria islandica</i> Showing Antiviral Activity against Influenza A Virus
by: E. V. Makarevich, et al.
Published: (2024-01-01)

The development and study of herbal composition for complex therapy of influenza A
by: A. Ali Alshami, et al.
Published: (2023-09-01)

Investigation of Ingavirin® Antiviral Activity Against Season Influenza Virus A/H1N1 in MDCK Cell Culture
by: G. A. Galegov, et al.
Published: (2020-05-01)

Guidelines on Prevention and Management of Influenza in Children in 2019/2020 yrs: American Academy of Pediatrics View
by: Vladmir K. Tatochenko
Published: (2019-11-01)

Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad‐Spectrum Efficacy against Corona and Influenza Viruses
by: Jan Lawrenz, et al.
Published: (2025-07-01)